A dendritic polypeptide nanogel for electrostatic adsorption of hydrogen sulfide on montmorillonite and a preparation method thereof
By loading DATS onto dendritic peptide nanogels and encapsulating montmorillonite, a drug delivery system for controlled H2S release was constructed, solving the problems of significant drug side effects and difficulty in delivering H2S donors in the treatment of colitis, and achieving long-acting sustained release and significant anti-inflammatory and antioxidant effects.
Patent Information
- Application Number
- CN202310556751.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-17
- Publication Date
- 2026-09-15
- Estimated Expiration
- 2043-05-17
AI Technical Summary
Existing colitis treatments suffer from significant side effects, difficulty in long-term use, poor targeting efficacy, and challenges in achieving controlled release and long-term delivery of H2S donor molecules.
A multifunctional drug delivery system for controlled H2S release was constructed by using dendritic polypeptide nanogels with hydrogen sulfide electrostatic adsorption on montmorillonite, loading diallyl trisulfide (DATS) molecules into the network structure of the dendritic polypeptide nanogels, and then encapsulating montmorillonite (MMT) on their surface.
It achieves long-term sustained release of DATS@PDNs@MMT, significantly inhibits the expression of inflammatory factors, promotes macrophage polarization to anti-inflammatory mode, reduces ROS concentration, promotes colonic epithelial cell proliferation and scratch repair, and has good anti-inflammatory and antioxidant stress resistance properties with high biocompatibility.